UnknownNot applicableNCT02022241

Repeated Injection of GnRH Agonist to Reduce Ovarian Hyperstimulation Syndrome

Studying Ovarian hyperstimulation syndrome

Last synced from ClinicalTrials.gov April 1, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: Chenshiling
Principal Investigator: Shi-Ling Chen, M.D., Ph.D.
Nanfang Hospital, Southern Medical University
Intervention: triptorelin(drug)
Enrollment: 80 target
Eligibility: 40 years · FEMALE
Timeline: 2012 – 2016

Study locations (1)

Center for Reproductive Medicine, Department of Gynecology and Obstetrics, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, China

Collaborators

National Natural Science Foundation of China · Comprehensive Strategic Cooperation Project of Guangdong Province and Chinese Academy of Science · Guangzhou Science and Technology Program key projects · National Key Basic Research Development Plan of China

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT02022241 on ClinicalTrials.gov

Other trials for Ovarian hyperstimulation syndrome

Additional recruiting or active studies for the same condition.

RECRUITINGPHASE2NCT07043322
Clinical Study to Evaluate Efficacy of Cabergoline to Coasting in Reducing the Incidence of Ovarian Hyperstimulation Syndrome
Tanta University

See all trials for Ovarian hyperstimulation syndrome →

← Back to all trials